These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25968090)

  • 1. Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease.
    Milian M; Kreitschmann-Andermahr I; Siegel S; Kleist B; Führer-Sakel D; Honegger J; Buchfelder M; Psaras T
    Neuroendocrinology; 2015; 102(1-2):60-7. PubMed ID: 25968090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people.
    Milian M; Teufel P; Honegger J; Gallwitz B; Schnauder G; Psaras T
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):861-7. PubMed ID: 22066792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing's disease patients in the course of the disease.
    Milian M; Honegger J; Teufel P; Wolf A; Psaras T
    Neuroendocrinology; 2013; 98(3):188-99. PubMed ID: 24080783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties.
    Milian M; Teufel P; Honegger J; Gallwitz B; Schnauder G; Psaras T
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):851-60. PubMed ID: 21801193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing's disease.
    Cusimano MD; Huang TQ; Marchie A; Smyth HS; Kovacs K
    Neurosurg Focus; 2020 Jun; 48(6):E4. PubMed ID: 32480368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related Quality of Life in Patients After Treatment of Cushing's Disease.
    Nader S; Burkhardt T; Vettorazzi E; Milian M; Aberle J; Petersenn S; Flitsch J
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):187-91. PubMed ID: 27008635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric evaluation of the Cushing's Quality-of-Life questionnaire.
    Nelson LM; Forsythe A; McLeod L; Pulgar S; Maldonado M; Coles T; Zhang Y; Webb SM; Badia X
    Patient; 2013; 6(2):113-24. PubMed ID: 23575965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.
    Siegel S; Milian M; Kleist B; Psaras T; Tsiogka M; Führer D; Koltowska-Häggström M; Honegger J; Müller O; Sure U; Menzel C; Buchfelder M; Kreitschmann-Andermahr I
    Pituitary; 2016 Dec; 19(6):590-600. PubMed ID: 27590785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.
    Webb SM; Badia X; Barahona MJ; Colao A; Strasburger CJ; Tabarin A; van Aken MO; Pivonello R; Stalla G; Lamberts SW; Glusman JE
    Eur J Endocrinol; 2008 May; 158(5):623-30. PubMed ID: 18426820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of quality of life in 102 patients with treated Cushing's disease.
    Carluccio A; Sundaram NK; Chablani S; Amrock LG; Lambert JK; Post KD; Geer EB
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):404-11. PubMed ID: 24931777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.
    Webb SM; Ware JE; Forsythe A; Yang M; Badia X; Nelson LM; Signorovitch JE; McLeod L; Maldonado M; Zgliczynski W; de Block C; Portocarrero-Ortiz L; Gadelha M
    Eur J Endocrinol; 2014 Jul; 171(1):89-98. PubMed ID: 24760537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary.
    Andela CD; Scharloo M; Ramondt S; Tiemensma J; Husson O; Llahana S; Pereira AM; Kaptein AA; Kamminga NG; Biermasz NR
    Pituitary; 2016 Jun; 19(3):293-302. PubMed ID: 26809957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in Cushing's syndrome.
    Santos A; Crespo I; Aulinas A; Resmini E; Valassi E; Webb SM
    Pituitary; 2015 Apr; 18(2):195-200. PubMed ID: 25647329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice.
    Santos A; Resmini E; Martínez-Momblán MA; Crespo I; Valassi E; Roset M; Badia X; Webb SM
    Eur J Endocrinol; 2012 Sep; 167(3):337-42. PubMed ID: 22677433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral adrenalectomy in Cushing's disease: Altered long-term quality of life compared to other treatment options.
    Sarkis P; Rabilloud M; Lifante JC; Siamand A; Jouanneau E; Gay E; Chaffanjon P; Chabre O; Raverot G
    Ann Endocrinol (Paris); 2019 Feb; 80(1):32-37. PubMed ID: 30243473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in presentation and outcome of patients with Cushing's disease in Han Chinese.
    Huan C; Qu Y; Ren Z
    Biomed Mater Eng; 2014; 24(6):3439-46. PubMed ID: 25227055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Quality of Life in Cushing's Disease.
    Ye VC; Akagami R
    Can J Neurol Sci; 2017 Jan; 44(1):69-77. PubMed ID: 27645104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients after long-term biochemical cure of Cushing's disease.
    van Aken MO; Pereira AM; Biermasz NR; van Thiel SW; Hoftijzer HC; Smit JW; Roelfsema F; Lamberts SW; Romijn JA
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3279-86. PubMed ID: 15741267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of depression, quality of life and body image in patients with Cushing's disease.
    Alcalar N; Ozkan S; Kadioglu P; Celik O; Cagatay P; Kucukyuruk B; Gazioglu N
    Pituitary; 2013 Sep; 16(3):333-40. PubMed ID: 22926673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.